NHS 批准为符合条件的患者开具糖尿病药物 Mounjaro 用于肥胖症治疗。 NHS approves prescribing Mounjaro, a diabetes drug, for obesity treatment in eligible patients.

英国国家医疗服务体系 (NHS) 已批准开出糖尿病药物 Mounjaro 来帮助对抗肥胖症。 The NHS has approved prescribing Mounjaro, a diabetes drug, to help fight obesity. Mounjaro 是一种胰高血糖素样肽 1 (GLP-1) 激动剂，已被法国国家健康与临床优化研究所 (Nice) 推荐用于体重指数 (BMI) 为 35 且至少患有一种肥胖相关疾病的患者。 Mounjaro, a glucagon-like peptide-1 (GLP-1) agonist, has been recommended by the National Institute for Health and Care Excellence (Nice) for patients with a body mass index (BMI) of 35 and at least one obesity-related condition. 预计该疗法将与低热量饮食和运动配合使用。 It is expected to be prescribed alongside a reduced-calorie diet and exercise.

June 04, 2024

6 文章